Copy Number Changes Are Associated with Response to Treatment with Carboplatin, Paclitaxel, and Sorafenib in Melanoma
about
CIViC database131I-Traced PLGA-Lipid Nanoparticles as Drug Delivery Carriers for the Targeted Chemotherapeutic Treatment of Melanoma.Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional Initiation.Thin and thick primary cutaneous melanomas reveal distinct patterns of somatic copy number alterations.Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.Emerging growth factor receptor antagonists for the treatment of advanced melanoma.Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition.Copy number variations in atypical fibroxanthomas and pleomorphic dermal sarcomas.Primary and Metastatic Melanoma With NTRK Fusions.
P2860
Q27612411-1EB57F2D-AC76-4EF9-90AF-25F790886F1FQ33708363-C08B9B78-04AE-4517-8CB0-E9D80DB08E94Q37286919-F3CAC0AE-50EA-4ADB-8FD2-31FBC0C0FE76Q37327493-8D86E0B0-3F2D-4FDD-82A1-FE3929F55BDBQ39043523-BE62A8CB-50DB-4E4B-86C9-8245B00276D5Q39340696-D29B9451-E685-40C7-8527-BF0D3B2CEFAFQ47566725-58B7BCEE-D13C-41B6-9C22-70C2E8D0A5C6Q49224855-F03B733F-7C1B-4BC5-A776-29F5C093F3A5Q52570211-9039613F-4FEA-4EAE-986C-DB859440FD32
P2860
Copy Number Changes Are Associated with Response to Treatment with Carboplatin, Paclitaxel, and Sorafenib in Melanoma
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Copy Number Changes Are Associ ...... xel, and Sorafenib in Melanoma
@ast
Copy Number Changes Are Associ ...... xel, and Sorafenib in Melanoma
@en
Copy Number Changes Are Associ ...... el, and Sorafenib in Melanoma.
@nl
type
label
Copy Number Changes Are Associ ...... xel, and Sorafenib in Melanoma
@ast
Copy Number Changes Are Associ ...... xel, and Sorafenib in Melanoma
@en
Copy Number Changes Are Associ ...... el, and Sorafenib in Melanoma.
@nl
altLabel
Copy Number Changes Are Associ ...... xel, and Sorafenib in Melanoma
@en
prefLabel
Copy Number Changes Are Associ ...... xel, and Sorafenib in Melanoma
@ast
Copy Number Changes Are Associ ...... xel, and Sorafenib in Melanoma
@en
Copy Number Changes Are Associ ...... el, and Sorafenib in Melanoma.
@nl
P2093
P2860
P50
P3181
P1476
Copy Number Changes Are Associ ...... xel, and Sorafenib in Melanoma
@en
P2093
Bradley Wubbenhorst
David L Rimm
Fengmin Zhao
Harriet M Kluger
John M Kirkwood
Katherine L Nathanson
Keith T Flaherty
Kurt D'Andrea
Lynn M Schuchter
Sandra J Lee
P2860
P304
P3181
P356
10.1158/1078-0432.CCR-15-1162
P407
P577
2016-01-15T00:00:00Z